Serum-based miRNAs in the prediction and detection of recurrence in melanoma patients. - Wikidata - wikimedia - TriplyDB

Serum-based miRNAs in the prediction and detection of recurrence in melanoma patients.

Serum-based miRNAs in the prediction and detection of recurrence in melanoma patients.

http://www.wikidata.org/entity/Q34735084

about

The Regulatory Roles of MicroRNAs in Bone Remodeling and Perspectives as Biomarkers in Osteoporosis Prognostic role of microRNA-150 in various carcinomas: a meta-analysis A novel microRNA signature predicts survival in stomach adenocarcinoma.A Seven-microRNA Expression Signature Predicts Survival in Hepatocellular Carcinoma.Comparison of a healthy miRNome with melanoma patient miRNomes: are microRNAs suitable serum biomarkers for cancer?MicroRNA-365 inhibits growth, invasion and metastasis of malignant melanoma by targeting NRP1 expression.The Prognostic and Predictive Value of Melanoma-related MicroRNAs Using Tissue and Serum: A MicroRNA Expression Analysis A miRNA-Based Signature Detected in Primary Melanoma Tissue Predicts Development of Brain Metastasis.Circulating microRNAs as prognostic therapy biomarkers in head and neck cancer patients.Revisiting determinants of prognosis in cutaneous melanoma.MicroRNA-425-5p regulates chemoresistance in colorectal cancer cells via regulation of Programmed Cell Death 10.MicroRNA profiling of patient plasma for clinical trials using bioinformatics and biostatistical approaches A panel of microRNA signature in serum for colorectal cancer diagnosis.miRNAs in melanoma: a defined role in tumor progression and metastasis.Aberrant regulation of miR-15b in human malignant tumors and its effects on the hallmarks of cancer.Epigenomic landscape of melanoma progression to brain metastasis: unexplored therapeutic alternatives.Circulating epigenetic biomarkers in melanoma.Liquid biopsy utility for the surveillance of cutaneous malignant melanoma patients Identification of plasma microRNAs as new potential biomarkers with high diagnostic power in human cutaneous melanoma.Metastatic pathways in patients with cutaneous melanoma.Conjunctival malignant melanoma in Denmark: epidemiology, treatment and prognosis with special emphasis on tumorigenesis and genetic profile.The Inescapable Influence of Noncoding RNAs in Cancer.Down-regulated miR-23a Contributes to the Metastasis of Cutaneous Melanoma by Promoting Autophagy.miR-30d is related to asbestos exposure and inhibits migration and invasion in NCI-H2452 cells Foe or friend? Janus-faces of the neurovascular unit in the formation of brain metastases.MicroRNA-21 antisense oligonucleotide improves the sensitivity of A375 human melanoma cell to Cisplatin: An in vitro study.MicroRNA-150 inhibitors enhance cell apoptosis of melanoma by targeting PDCD4.Non coding RNA analysis in fibrolamellar hepatocellular carcinoma.Circulating miR-148/152 family as potential biomarkers in hepatocellular carcinoma.MiR-497-5p, miR-195-5p and miR-455-3p function as tumor suppressors by targeting hTERT in melanoma A375 cells.Circulating MicroRNA Biomarkers in Melanoma: Tools and Challenges in Personalised Medicine.miRNA expression profiles of premalignant and malignant arsenic-induced skin lesions Metabolic reprogramming of stromal fibroblasts by melanoma exosome microRNA favours a pre-metastatic microenvironment Liquid biopsy and PCR-free ultrasensitive detection systems in oncology (Review)

P2860

Q26748699-69DD394F-8857-4B1D-BB64-C1F69FF1C1C1 Q26752827-4965282A-04A4-4079-837A-2956E8E10CE1 Q33709612-26DB3F6F-5A1D-4B0D-8EDA-2E2EFEB4B498 Q35654057-742C46FF-8783-48B1-B5A0-37E006066353 Q35828512-ADB3EFB8-D402-43E2-AD63-D4DF6FD99188 Q35853997-C46B9CC0-F318-4988-A575-BC557F30074D Q35947544-CACB4346-D7DA-454E-B442-98139835F61B Q36244744-5DE9EEBF-7A8C-48C9-887D-6B4CA20F1083 Q36286699-6C847CF0-E7EC-462E-B739-6FABBA252CDF Q36338825-4436EEA6-8DD9-4C43-A7F2-A4F203416B87 Q36504323-9C807CA0-B7E4-4548-AB94-A3D2D89DED71 Q37305975-2E3F074C-C71B-4120-B5B8-0276ED410214 Q37725573-4B1AF233-2817-46E9-A67C-D66DCFCBBA34 Q38617229-BEC4AAFF-EC3D-4BB0-B182-0B9DFA6A897F Q38639540-07993675-493C-4946-8616-777EA478332A Q38660042-F34473D5-E5F9-4FA1-A9D4-C9811642AE5F Q38668171-85E29F0A-CFE4-49D8-85E7-C9BD6575A2DB Q38700529-AF0EE4F1-F52F-4249-90F1-2193372DFAB3 Q38807433-ABA7D720-4920-4A7E-BC98-251742718813 Q39024316-B6B5A459-3F13-4240-8F4C-05EC92D5BB14 Q39756781-45333063-6B66-4026-8001-D7111A8409B9 Q39927058-53974B61-435E-45D7-A7F7-74EF70BFABFF Q40980381-D58187E4-30F7-4790-B7D8-2EE6EF59455C Q42022545-017E7575-C5A0-4B0F-976C-3475917831BC Q48108646-0C827B85-25A6-4193-814E-0D0781E6E337 Q48146192-069C56F4-36AE-4563-A390-86DFDEFE2EF2 Q49647487-273381C8-BD32-48B4-A9DB-5B69A65B7B8F Q52657106-3423A90D-E5A7-4E6A-A06B-EF7D9B2A9755 Q53289839-AAA6CE95-033C-4EB4-A037-E63FC38F0091 Q55027570-B6DBF15F-42E7-412D-ADD1-6D30FA1B3DDA Q55428812-D5F34F66-FB17-498C-9A8F-E32B7F9D31B8 Q57940614-A56F9C90-C41F-4DB7-AF6E-3510D71199C8 Q58701218-E3ADB170-283A-45A7-8F4B-340A3FFFB696 Q58799160-1A24B529-1562-4C3C-AC4A-DD7C6B812419

P2860

Serum-based miRNAs in the prediction and detection of recurrence in melanoma patients.

http://www.wikidata.org/entity/Q34735084

description

2014 nî lūn-bûn

@nan

2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Serum-based miRNAs in the prediction and detection of recurrence in melanoma patients.

@ast

Serum-based miRNAs in the prediction and detection of recurrence in melanoma patients.

@en

Serum-based miRNAs in the prediction and detection of recurrence in melanoma patients.

@nl

type

label

Serum-based miRNAs in the prediction and detection of recurrence in melanoma patients.

@ast

Serum-based miRNAs in the prediction and detection of recurrence in melanoma patients.

@en

Serum-based miRNAs in the prediction and detection of recurrence in melanoma patients.

@nl

prefLabel

Serum-based miRNAs in the prediction and detection of recurrence in melanoma patients.

@ast

Serum-based miRNAs in the prediction and detection of recurrence in melanoma patients.

@en

Serum-based miRNAs in the prediction and detection of recurrence in melanoma patients.

@nl

P1433

Q34735084-9A4F7DE5-11CE-4F31-9F06-668270158F2F

P1476

Q34735084-8F809FF1-3E64-47F5-AE1F-9D6C3142895B

P2093

Q34735084-0EFAE959-F707-4314-9C43-E622792AF52D

Q34735084-1A39EC92-0F87-4992-853F-399D2E2265F7

Q34735084-1C2C7D89-13D7-4067-BFEC-F596C7A066E2

Q34735084-A2DAE461-EE94-4643-A62D-C13A4627D886

Q34735084-C3940A73-B602-4618-B391-977812FC9B30

Q34735084-CF95A32D-1ECA-45F0-BC32-5531F764AAF1

Q34735084-F3785D95-8862-444C-AFEC-E242EA486659

Q34735084-F9F7C228-F44C-4732-B638-C5265254F91C

P2860

Q34735084-08416941-3DE4-4349-8F1F-5281A07F792D

Q34735084-0CFA6274-14F2-492B-8012-DDE2A77B84E3

Q34735084-1151B134-7D76-4EB8-A222-9837C1FBE587

Q34735084-16C35BD4-6564-4DA9-A634-13C0E82FB05F

Q34735084-1FA76084-ED8F-4AF7-93CD-01B5B1D9A1CC

Q34735084-217F949A-F1C9-4D20-81A8-6ADE2CDFED85

Q34735084-34246D66-3F25-4D0D-8A6F-976963C45702

Q34735084-4EF04C10-76DB-4ABF-A855-B7ED921B2045

Q34735084-6673BC01-B139-4642-88C7-A937663C6BDD

Q34735084-6F67597C-6CCB-45C1-98FD-4E6D6E3C39FC

P304

Q34735084-0D95E546-450D-4AC3-9912-E78F9441EB0F

P31

Q34735084-45D092BB-0CDE-473D-ACC8-F28E8E0C8C24

P356

Q34735084-053E454F-1EF1-4E73-8FB7-21BCEB15582A

P407

Q34735084-7E93A8E7-9A68-4025-80B8-4DC46DBAACFD

P433

Q34735084-9BE98052-470B-4BA9-A809-387FD7D1CE68

P478

Q34735084-FA1741BB-D229-4B3F-B7D0-078BB2C6752D

P50

Q34735084-93B6524F-8ECE-45DA-89A3-9E004C76270B

Q34735084-BEA7FA1E-D900-402A-AD7C-5F9DA7D53F29

Q34735084-F4B9A6B6-7372-4F78-A1EA-BE76A0BF0C8E

P577

Q34735084-769C5E6C-F291-4450-8391-D54753CDAE5B

P698

Q34735084-F20F85D1-9C0E-4500-A215-D29DA4D9B8D4

P921

Q34735084-07D54C8A-FA37-4423-8CF0-6E62D8C59A9A

P932

Q34735084-1994AFAA-7D22-4BEF-981D-B90C5E82F9A9

P356

P1433

P1476

Serum-based miRNAs in the prediction and detection of recurrence in melanoma patients.

@en

P2093

Bobbi Brady

http://www.w3.org/2001/XMLSchema#string

Eleazar Vega-Saenz de Miera

http://www.w3.org/2001/XMLSchema#string

Iman Osman

http://www.w3.org/2001/XMLSchema#string

Inês Pires da Silva

http://www.w3.org/2001/XMLSchema#string

Jinhua Wang

http://www.w3.org/2001/XMLSchema#string

Nathaniel H Fleming

http://www.w3.org/2001/XMLSchema#string

Richard L Shapiro

http://www.w3.org/2001/XMLSchema#string

Sung Won Han

http://www.w3.org/2001/XMLSchema#string

P2860

Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets

Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma

MITF: master regulator of melanocyte development and melanoma oncogene

Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma

Final version of 2009 AJCC melanoma staging and classification

Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets

CXC chemokine receptor 3 expression by activated CD8+ T cells is associated with survival in melanoma patients with stage III disease.

The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer Society.

MicroRNAs in renal cell carcinoma: diagnostic implications of serum miR-1233 levels.

The epidemiology of skin cancer.

P304

51-59

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CNCR.28981

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

121

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-08-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25155861

http://www.w3.org/2001/XMLSchema#string

P921

P932

4270907

http://www.w3.org/2001/XMLSchema#string